Opioid Endocrinopathy: A Clinical Problem in Patients With Chronic Pain and Long-term Oral Opioid Treatment
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background: The use of strong opioids for treatment of noncancer chronic pain has increased. However, strong evidence for sustained pain relief and improved function is lacking. Controversy prevails, whether hormonal changes are induced by long-term treatment with opioids. The purpose of this study was to investigate the occurrence of endocrine dysfunction in chronic pain patients on long-term opioid treatment. Methods: A study group of 39 chronic pain patients treated with strong oral opioids for more than 1 year was compared with a control group of 20 chronic pain patients without opioid treatment. Basic levels of prolactin and function of the hypothalamic-pituitary-thyroid-, hypothalamic-pituitary-adrenal-axis, and hypothalamic-pituitary-growth-hormone - and hypothalamic-pituitary-gonadal-axis were measured. Quality-of-life and side effects were estimated with EORTC-QLQ-C30. Results: In the opioid-treated group, the patients had signs of pituitary dysfunction affecting all axes. Significant differences were shown in hypofunction of the hypothalamic-pituitary-gonadal -axis, hyperfunction of the hypothalamic-pituitary-adrenal -axis, and higher prolactin levels in the opioid-treated group, compared with the control group. The degree of pain was rated the same in both groups, but the opioid-treated group reported more side effects and lower quality of life. Conclusions: Long-term treatment of chronic pain with strong opioids causes side effects that can be attributed to hormonal abnormalities caused by opioid-induced inhibition of hypothalamic-pituitary function. Hormone substitution can be indicated to treat symptoms. Decreasing the opioid dose or stopping the opioid treatment can reverse endocrine dysfunction. This needs to be recognized by all practitioners treating chronic pain patients with opioids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study evaluated 39 noncancer pain patients who received different oral opioids and 20 controls (118); GH stimulation test was not performed but mean serum IGF-I was lower in the opioid-treated group, although statistical significance was not attained.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“Variable results have also been described for the peripheral thyroid hormones; T4 levels were unaffected (74, 118, 136, 159, 160) or decreased (116, 160-162) and T3 levels were increased (74, 159) or unaffected (160) or decreased (161).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“Studies with dynamic thyrotropin-releasing hormone test performed in chronic opioid users have demonstrated conflicting results with enhanced (118), blunted (136, 155, 156), or no (74, 157) TSH response.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“In a group of 39 noncancer pain patients on oral opioids, hyperprolactinemia was detected in approximately 40% of them (118).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216 · cited 1×
“Number 39 20 Gender (M/F) 15/24 8/12 Mean age (range) 48 (32-63) 49 (32-63) Mean years with pain (range) 13 (4-30) 12 (4-23) Causes of pain”
Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
Portenoy, R. K., & Foley, K. M. (1986) · Pain · doi:10.1016/0304-3959(86)90091-6 · Cited by 897
Equianalgesic Dose Ratios for Opioids
Pereira, J., Lawlor, P., Vigano, A., Dorgan, M., & Bruera, E. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00294-9 · Cited by 537
Critical issues on opioids in chronic non-cancer pain:
Eriksen, J., Sjøgren, P., Bruera, E., Ekholm, O., & Rasmussen, N. K. (2006) · Pain · doi:10.1016/j.pain.2006.06.009 · Cited by 515
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel, J. S., Richards, P., & Portenoy, R. K. (2003) · Neurology · doi:10.1212/01.wnl.0000057720.36503.2c · Cited by 469
Chronic Pain in Canada ‐ Prevalence, Treatment, Impact and the Role of Opioid Analgesia
Moulin, D. E., Clark, A. J., Speechley, M., & Morley-Forster, P. K. (2002) · Pain Research and Management · doi:10.1155/2002/323085 · Cited by 443
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Cited by
Portenoy, R. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60236-5 · Cited by 487
Stein, C. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093100 · Cited by 480
McNicol, E. D., Midbari, A., & Eisenberg, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006146.pub2 · Cited by 434
Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women
Bateman, B. T., Franklin, J. M., Bykov, K., Avorn, J., Shrank, W. H., Brennan, T. A., Landon, J. E., Rathmell, J. P., Huybrechts, K. F., Fischer, M. A., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.016 · Cited by 286
A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner’s Guide
Baldini, A., Von Korff, M., & Lin, E. H. B. (2012) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.11m01326 · Cited by 260
Haroutounian, S., Ratz, Y., Ginosar, Y., Furmanov, K., Saifi, F., Meidan, R., & Davidson, E. (2016) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000364 · Cited by 234
Shanthanna, H., Strand, N. H., Provenzano, D. A., Lobo, C. A., Eldabe, S., Bhatia, A., Wegener, J., Curtis, K., Cohen, S. P., & Narouze, S. (2020) · Anaesthesia · doi:10.1111/anae.15076 · Cited by 218
Principles of Opioid Use in Cancer Pain
Portenoy, R. K., & Ahmed, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.5188 · Cited by 214
The Effect of Opioid Therapy on Endocrine Function
Brennan, M. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.001 · Cited by 166
Opioid use for noncancer pain and risk of myocardial infarction amongst adults
Li, L., Setoguchi, S., Cabral, H., & Jick, S. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12035 · Cited by 156
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Opioid therapy for treating rheumatoid arthritis pain
Whittle, S., Richards, B. L., Husni, M. E., & Buchbinder, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003113.pub3 · Cited by 130
Medical and Psychological Risks and Consequences of Long-Term Opioid Therapy in Women
Darnall, B. D., Stacey, B. R., & Chou, R. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01467.x · Cited by 109
Prescribed opioid analgesic use developments in three Nordic countries, 2006–2017
Muller, A. E., Clausen, T., Sjøgren, P., Odsbu, I., & Skurtveit, S. O. (2019) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2018-0307 · Cited by 108
Khodneva, Y. A., Muntner, P., Kertesz, S. G., Kissela, B. M., & Safford, M. M. (2016) · Pain Medicine · doi:10.1111/pme.12916 · Cited by 102
Association of opioid misuse with anxiety and depression: A systematic review of the literature
Rogers, A. H., Zvolensky, M. J., Ditre, J. W., Buckner, J. D., & Asmundson, G. J. G. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.101978 · Cited by 97
Opioid-Induced Adrenal Insufficiency
Donegan, D., & Bancos, I. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.010 · Cited by 78
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Birke, H., Kurita, G. P., Sjøgren, P., Højsted, J., Simonsen, M. K., Juel, K., & Ekholm, O. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12700 · Cited by 76
Opioid Related Endocrinopathy: Table 1
Gudin, J. A., Laitman, A. P., & Nalamachu, S. R. (2015) · Pain Medicine · doi:10.1111/pme.12926 · Cited by 74
Kotlińska-Lemieszek, A., & Zylicz, Z. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s342409 · Cited by 74
MECHANISMS OF ENDOCRINOLOGY: endocrinology of opioids
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0270 · Cited by 60
Opioids in chronic non-cancer pain
Chan, B. K. B., Tam, L. K., Wat, C. Y., Chung, Y. F., Tsui, S. L., & Cheung, C. W. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.536335 · Cited by 58
The Role of the Health Insurance Industry in Perpetuating Suboptimal Pain Management
Schatman, M. E. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01061.x · Cited by 56
Lamprecht, A., Sorbello, J., Jang, C., Torpy, D. J., & Inder, W. J. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0530 · Cited by 52
Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids
Li, T., Cunningham, J. L., Gilliam, W. P., Loukianova, L., Donegan, D. M., & Bancos, I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa499 · Cited by 51
Gupta, P., Gaines, N., Sirls, L. T., II, & Peters, K. M. (2015) · PubMed Central · doi:10.3978/j.issn.2223-4683.2015.10.10 · Cited by 48
The effects of HIV-1 infection on endocrine organs
Brown, T. T. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.04.005 · Cited by 44
Pain Medications and Male Reproduction
Drobnis, E. Z., & Nangia, A. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-69535-8_6 · Cited by 42
Opioid‐induced hypogonadism: Pathophysiology, clinical and therapeutics review
Antony, T., Alzaharani, S. Y., & El-Ghaiesh, S. H. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13246 · Cited by 42
Opioids and the Hypothalamic-Pituitary-Gonadal (HPG) Axis
Wehbeh, L., & Dobs, A. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa417 · Cited by 39
Casomorphins and Gliadorphins Have Diverse Systemic Effects Spanning Gut, Brain and Internal Organs
Woodford, K. B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18157911 · Cited by 39
The Cholinergic System as a Treatment Target for Opioid Use Disorder
Jensen, K. P., DeVito, E. E., Yip, S. W., Carroll, K. M., & Sofuoglu, M. (2018) · CNS Drugs · doi:10.1007/s40263-018-0572-y · Cited by 38
A Closer Look at Opioid-Induced Adrenal Insufficiency: A Narrative Review
Coluzzi, F., LeQuang, J. A., Sciacchitano, S., Scerpa, M. S., Rocco, M., & Pergolizzi, J. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054575 · Cited by 36
Demarest, S. P., Gill, R. S., & Adler, R. A. (2014) · Endocrine Practice · doi:10.4158/ep14339.ra · Cited by 35
Greis, A. C., Larsen, E., Liu, C., Renslo, B., Radakrishnan, A., & Wilson‐Poe, A. R. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0088 · Cited by 40
Ljungvall, H., Rhodin, A., Wagner, S., Zetterberg, H., & Åsenlöf, P. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-3055-5 · Cited by 33
Self-citationThe effect of opium addiction on serum adiponectin and leptin levels in male subjects
Shahouzehi, B., Shokoohi, M., & Najafipour, H. (2013) · EXCLI journal · doi:10.17877/de290r-7228 · Cited by 32
The Efficacy and Safety of Opioids in Inflammatory Arthritis: A Cochrane Systematic Review
Whittle, S., Richards, B. L., van der Heijde, D. M. F. M., & Buchbinder, R. (2012) · Journal of Rheumatology Supplement · doi:10.3899/jrheum.120341 · Cited by 31
Long-term Opioids Linked to Hypogonadism and the Role of Testosterone Supplementation Therapy
Marudhai, S., Patel, M., Subas, S. V., Ghani, M. R., Busa, V., Dardeir, A., & Cancarevic, I. (2020) · Cureus · doi:10.7759/cureus.10813 · Cited by 29
Tait, M.-A., Costa, D. S. J., Campbell, R., Norman, R., Warne, L. N., Schug, S. A., & Rutherford, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290549 · Cited by 29
Opioids and neovascularization; pro or anti?
Mahbuba, W. A., & Lambert, D. G. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev357 · Cited by 29
Yang, B., Zhou, H., Cheng, Z., Kranzler, H. R., & Gelernter, J. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-53560-0 · Cited by 28
Opioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Clinical presentation and outcomes of opioid-induced adrenal insufficiency
Li, T., Donegan, D., Hooten, W. M., & Bancos, I. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0297 · Cited by 27
Endorphins, oxytocin, sexuality and romantic relationships: An understudied area
Khajehei, M., & Behroozpour, E. (2018) · World Journal of Obstetrics and Gynecology · doi:10.5317/wjog.v7.i2.17 · Cited by 26
Opioid induced adrenal insufficiency: what is new?
Donegan, D. M. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000474 · Cited by 24
Sexual Functioning and Opioid Maintenance Treatment in Women. Results From a Large Multicentre Study
Zamboni, L., Franceschini, A., Portoghese, I., Morbioli, L., Lugoboni, F., & GICS Group (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00097 · Cited by 25
Breivik, H., & Stubhaug, A. (2014) · Pain · doi:10.1016/j.pain.2014.09.011 · Cited by 24
Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
Guan, Q., Velho, R. V., Sehouli, J., & Mechsner, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021633 · Cited by 23
Birke, H., Ekholm, O., Højsted, J., Sjøgren, P., & Kurita, G. P. (2018) · Pain Medicine · doi:10.1093/pm/pny122 · Cited by 23
Wersocki, E., Bedson, J., Chen, Y., LeResche, L., & Dunn, K. M. (2017) · Pain · doi:10.1097/j.pain.0000000000000691 · Cited by 21
“Several of the studies recognised having samples that were unrelated to the menstrual cycle as a limitation.(4,9,17,19,30,35,36) Aurilio et al.”
BackgroundResultInfluentialOh, T. K., Song, I., Lee, J. H., Lim, C., Jeon, Y.-T., Bae, H., Jo, Y. H., & Jee, H. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.03.032 · Cited by 21
Current Knowledge and Practices of Heath Care Professionals on Opioid-Induced Adrenal Insufficiency
Saeed, Z. I., Bancos, I., & Donegan, D. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0177 · Cited by 20
Bianco, G. L., Papa, A., Schatman, M. E., Tinnirello, A., Terranova, G., Leoni, M. L. G., Shapiro, H., & Mercadante, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112303 · Cited by 19
Salama-Hanna, J., & Chen, G. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.07.005 · Cited by 19
Rajguru, P., Kolber, M. J., Garcia, A. N., Smith, M. T., Patel, C. K., & Hanney, W. J. (2015) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614522580 · Cited by 18
Corsi, D. J., & Murphy, M. S. Q. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13577 · Cited by 17
Chronic administration of morphine using mini-osmotic pumps affects spatial memory in the male rat
Brolin, E., Zelleroth, S., Jonsson, A., Hallberg, M., Grönbladh, A., & Nyberg, F. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.01.007 · Cited by 17
Systemic Complications of Complex Regional Pain Syndrome
Schwartzman, R. J. (2012) · Neuroscience & Medicine · doi:10.4236/nm.2012.33027 · Cited by 16
Bai, X., Wang, C., Zhang, X., Feng, Y., & Zhang, X. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134868 · Cited by 16
Breivik, H., & Stubhaug, A. (2016) · Pain · doi:10.1097/j.pain.0000000000000745 · Cited by 16
Finch, P. M., Price, L. M., Pullan, P. T., & Drummond, P. D. (2015) · Pain Practice · doi:10.1111/papr.12190 · Cited by 15
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Recent advances in opioid prescription for chronic non-cancer pain
Snidvongs, S., & Mehta, V. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.112045 · Cited by 14
Salarinasab, S., Nourazarian, A., Nikanfar, M., Abdyazdani, N., Kazemi, M., Feizy, N., & Rahbarghazi, R. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.035 · Cited by 13
Management of opioid substitution therapy during medical intervention
Murnion, B. P. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02714.x · Cited by 13
Ray, J. A., Kushnir, M. M., Meikle, A. W., Sindt, J. E., & Strathmann, F. G. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2174 · Cited by 12
Liew, S., Chowdhury, E., Ernst, M. E., Gilmartin‐Thomas, J., Reid, C. M., Tonkin, A. M., Neumann, F., McNeil, J. J., & Kaye, D. M. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14101 · Cited by 12
Vallath, N., Damani, A., Ghoshal, A., Salins, N. S., Bhatnagar, S., Sanghavi, P., Viswanath, V., Ostwal, S., & Chinchalkar, G. (2020) · Indian Journal of Palliative Care · doi:10.4103/ijpc.ijpc_216_20 · Cited by 12
Kondo, A., Murakami, T., Fujii, T., Tatsumi, M., Ueda-Sakane, Y., Ueda, Y., Yamauchi, I., Ogura, M., Taura, D., & Inagaki, N. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0359 · Cited by 11
Ramli, F. F., Azizi, M. H., & Hashim, S. A. S. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.57641 · Cited by 11
Stress Axis in the Cancer Patient: Clinical Aspects and Management
Felicetti, F. C., Nervo, A., Gatti, F., Rosso, D., Brignardello, E., & Arvat, E. (2021) · Endocrines · doi:10.3390/endocrines2040044 · Cited by 11
Endocrine Effects of Chronic Opioid Therapy: Implications for Clinical Management
Elliott, J. A., & Fibuch, E. E. (2013) · Pain Management · doi:10.2217/pmt.13.13 · Cited by 10
The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism
Balodimos, S., Nikolaou, K., Njau, S., Karamouzis, M., & Kovatsi, L. (2015) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2015.1068321 · Cited by 9
Effects of Intrathecal Opioid Administration on Pituitary Function
Xenidis, M. E., Pandya, N., & Hames, E. (2013) · Pain Medicine · doi:10.1111/pme.12205 · Cited by 9
Taghavi, S. F., Shahsavari, Z., Adjaminezhad-Fard, F., Ghorbani, M., Ghorbanhosseini, S. S., Salimi, V., & Tavakoli‐Yaraki, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114022 · Cited by 9
Tafreshi, S., Steiner, A., & Sud, A. (2022) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13680 · Cited by 8
U-PAIN cohort study among patients with chronic pain in specialised pain care: a feasibility study
Ljungvall, H., Lind, A., Zetterberg, H., Wagner, S., Ekselius, L., Karlsten, R., Heilig, M. A., & Åsenlöf, P. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062265 · Cited by 8
Fredheim, O. M. S., Skurtveit, S. O., Loge, J. H., Sjøgren, P., Handal, M., & Hjellvik, V. (2020) · Pain · doi:10.1097/j.pain.0000000000001800 · Cited by 8
Corriger, A., Duclos, M., Corcuff, J., Lambert, C., Marceau, G., Sapin, V., Macian, N., Roux, D., Pereira, B., & Pickering, G. P. (2019) · Pain Practice · doi:10.1111/papr.12800 · Cited by 8
Abou-Kassem, D., Kurita, G. P., Sjøgren, P., & Diasso, P. D. K. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0196 · Cited by 7
Patel, B. P., & Loweth, J. A. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1473164 · Cited by 7
The Five Pillars of Pain Management
GORDON, A. S. (2012) · Pain Management · doi:10.2217/pmt.12.31 · Cited by 7
Opioid-induced biochemical alterations of the neuroendocrine axis
Thosani, S., & Jiménez, C. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.55 · Cited by 6
Endorphins, Sexuality, and Reproduction
Khajehei, M. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-45493-6_20 · Cited by 6
Endocrinopathy of the Critically Ill
Aerde, N. V., Dyck, L. V., Vanhorebeek, I., & den Berghe, G. V. (2019) · Lessons from the ICU · doi:10.1007/978-3-030-24250-3_9 · Cited by 6
Turner, S., Allen, V. M., Graves, L. E., Tanguay, R. L., Green, C. R., & Cook, J. L. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.05.011 · Cited by 6
Why It Is Important to Consider the Effects of Analgesics on Sleep: A Critical Review
Iacovides, S., Kamerman, P. R., Baker, F. C., & Mitchell, D. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210006 · Cited by 5
Medina, W. A., & Conermann, T. (2021) · StatPearls · Cited by 5
Breivik, H. (2014) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2014.08.006 · Cited by 5
Disagreements between Medical Specialty Boards and their Diplomates
Waisel, D. B. (2015) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2015.17.3.spec1-1503 · Cited by 4
Osteoporosis: The Need for Prevention and Treatment
Baucom, K., Pizzorno, L., & Pizzorno, J. E. (2014) · Journal of Restorative Medicine · doi:10.14200/jrm.2014.3.0102 · Cited by 4
Ljungvall, H., Öster, C., Katila, L., & Åsenlöf, P. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0171 · Cited by 4
[Gender mainstreaming and nursing].
Wang, H. (2011) · PubMed · Cited by 4
Aceituno, H., Lanz‐Luces, J. R., Lanz-Luces, J. A., Lander, G., da Costa, F. A., & Díaz, H. (2020) · Gaceta Médica de Caracas · doi:10.47307/gmc.2020.128.s1.5 · Cited by 3
Chronic Pain Management in the Homeless Population
Pangarkar, S. S., & Chang, L. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-70135-2_4 · Cited by 3
A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain
Tabuchi, Y., Yasuda, T., Kaneto, H., Kitamura, T., Kozawa, J., Otsuki, M., Imagawa, A., Nakae, A., Matsuda, Y., Uematsu, H., et al. (2012) · Case Reports in Medicine · doi:10.1155/2012/740603 · Cited by 3
COVID-19 PANDEMIC AND CHRONIC PAIN MANAGEMENT: IMPACT AND SUGGESTIONS
Maan, M. A. M., Siddique, A., Iqbal, R., & Ahmad, K. (2020) · Pakistan Armed Forces Medical Journal · Cited by 3
Hypothalamic Regulation of Prolactin Secretion
Wilkinson, M., & Imran, S. A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108149938.008 · Cited by 3
Metadata
- Authors
- Rhodin, A., Stridsberg, M., & Gordh, T.
- Affiliations
- Uppsala University Hospital (SE)
- Corresponding author
- Rhodin, Annica
- Gordh, Torsten
- Venue
- The Clinical Journal of Pain
- Published
- 2010-06
- Volume
- 26
- Issue
- 5
- Pages
- 374-380
- ISSN
- 0749-8047 (ISSN-L)
- OpenAlex
- W2122866774
- Semantic Scholar
- 7f03806c4c29c1464ecc1c49a8b90e6490bbf01d
- Cited by
- 142
- References
- 36
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 15 · 2020: 12 · 2019: 13 · 2018: 11 · 2017: 5 · 2016: 5 · 2015: 10 · 2014: 12 · 2013: 9 · 2012: 9
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- long-term opioid therapy, chronic non-cancer pain, prolactin, hypothalamic-pituitary-gonadal axis, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-thyroid axis, endocrine dysfunction, quality of life, opioid side effects, hormone replacement therapy
- MeSH terms
- Adult, Analgesics, Opioid, Chronic Disease, Drug Administration Schedule, Endocrine System Diseases, Estradiol, Female, Health Status, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Menstrual Cycle, Middle Aged, Pain, Pain Measurement, Pituitary Hormones, Anterior, Pituitary-Adrenal System, Quality of Life, Testosterone, Patient Selection, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.